Literature DB >> 31182267

Spinocerebellar ataxia with axonal neuropathy type 1 revisited.

Patrick Scott1, Adila Al Kindi2, Amira Al Fahdi1, Naeema Al Yarubi1, Zandre Bruwer2, Samir Al Adawi3, Ramachandiran Nandhagopal4.   

Abstract

Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1; OMIM #607250), an exceedingly rare disorder having been documented in only a single family from Saudi Arabia, is the result of an unusual mutation in the tyrosyl DNA phosphodiesterase 1 gene (TDP1). We performed high-throughput sequencing (whole exome and ataxia gene panel) in two apparently unrelated Omani families segregating sensorimotor neuropathy and ataxia in an autosomal recessive fashion. Following validation by Sanger sequencing, all affected subjects (n = 4) were confirmed to carry the known SCAN1 pathogenic homozygous variant in the TDP1 gene, NM_001008744.1:c.1478A > G (p.His493Arg). In keeping with the initial description, our patients demonstrated progressive ataxia, cerebellar atrophy and disabling axonal sensori-motor neuropathy (n = 4), hypercholesterolemia (n = 2) and elevated serum alpha fetoprotein (n = 3). In addition, our patients also had mild cognitive deficits in multiple domains (n = 3), a feature not previously reported. Our findings independently revalidate the phenotype of TDP1 mutation and expand the clinical spectrum to include mild cognitive deficits. Haplotype sharing, as determined by DNA microarray (CytoScan HD), attests to a possible common founder mutation in the Arab population.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Distal motor sensory neuropathy; Recessive ataxia; TDP1 mutation

Mesh:

Substances:

Year:  2019        PMID: 31182267     DOI: 10.1016/j.jocn.2019.05.060

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Ancient founder mutation in RUBCN: a second unrelated family confirms Salih ataxia (SCAR15).

Authors:  Mohammed Z Seidahmed; Muddathir H Hamad; Albandary AlBakheet; Salah A Elmalik; Abdulmajeed AlDrees; Jumanah Al-Sufayan; Ibrahim Alorainy; Ibrahim M Ghozzi; Dilek Colak; Mustafa A Salih; Namik Kaya
Journal:  BMC Neurol       Date:  2020-05-25       Impact factor: 2.474

Review 2.  Tyrosyl-DNA Phosphodiesterase I N-Terminal Domain Modifications and Interactions Regulate Cellular Function.

Authors:  Evan J Brettrager; Isaac A Segura; Robert C A M van Waardenburg
Journal:  Genes (Basel)       Date:  2019-11-06       Impact factor: 4.096

3.  Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts.

Authors:  Evan J Brettrager; Robert C A M van Waardenburg
Journal:  Cancer Drug Resist       Date:  2019-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.